Mesoblast announces retirement of directors William Burns and Philip Krause
MESO•William Burns will retire at Mesoblast’s 2026 annual general meeting after 12 years on the board, and Philip Krause will also retire. Jane Bell will succeed Burns as Nomination and Remuneration Committee chair, while the company plans to recruit directors with U.S. and global commercial expertise.
1. Board changes
Burns, a director since 2014, will retire at the 2026 annual general meeting. Krause, who joined the board in 2022, will also retire. Jane Bell, co-chair of the Nomination and Remuneration Committee since April 2026, will become its chair. Mesoblast plans to recruit directors with U.S. and global commercial expertise in biotechnology and pharmaceuticals to support commercial growth.
